In fact, there is a reason to think M&A activity will remain highish. Valuations were insane before the world got a reality check, and now more attractive prices will lure those with cash piles back into the M&A market.

Research institutions, philanthropic funds, pharma companies, startups, and more have teamed up to accelerate the development of and expand access to Covid-19 tests, vaccines, treatments, and critical medical equipment.

To see all 170+ connections between over 200 organizations, take a look at our State of Healthcare Q1’20 report, which explores some of these partnerships in detail and surveys the healthcare sector in the wake of Covid-19. The report is free to download.